News Archive

PerVista, Inc., located in Oxon Hill, Md., a company developing artificial intelligence (AI) solutions that will support a proactive approach to threat detection. By analyzing electro optical signals from drones and surveillance cameras, the company offers personalized security solutions to all

The program is intended to help a wide swath of businesses, from "main street" companies to technology startups.

TEDCO, Maryland’s economic engine for technology companies, announced a recent Builder Fund investment in JuneBrain Inc., a biotechnology company. TEDCO’s Pre-Seed Builder Fund is part of TEDCO’s Social Impact Funds, which were created to engage and invest in economically underserved founders and

TEDCO, Maryland’s economic engine for technology companies, announced a recent Pre-Seed Rural Business Innovation Initiative (RBII) Fund investment in Goby Homes.

Black women entrepreneurs are a dynamic force driving economic growth, yet systemic challenges continue to impede their success. According to the World Economic Forum, in 2021, Black women startup founders received just 0.34% of the total venture capital spent in the U.S., and this figure has seen a

NEOPATHOLOGY CORP., located in Frederick, Md., is a biotechnology research and clinical diagnostic company developing more accurate and rapidly reported primarily image-based tissue diagnostics and assays. Its proprietary diagnostic process ONEPATHOLOGY™, an end-to-end learning solution seeks to

Nonadherence to therapy in chronic disease leads to poor outcomes and high cost. It is estimated that the rate of adherence to chronic medications is only in the range of 50%, which is responsible for half of all treatment failures and up to 25% of US hospitalizations each year. Because of this

TEDCO, Maryland’s economic engine for technology companies, announced a recent round of investments through its Maryland Innovation Initiative (MII), marking a significant milestone in promoting the commercialization of groundbreaking research from Maryland’s prestigious academic institutions.

TEDCO, Maryland’s economic engine for technology companies, is pleased to announce the promotion of Kim Mozingo to vice president of Federal Programs. In this role, Mozingo will lead a suite of seven programs designed to transform federal scientific research into economic growth and new job

TEDCO, Maryland’s economic engine for technology companies, announced a recent round of investments through its Maryland Innovation Initiative, marking a significant milestone in promoting the commercialization of groundbreaking research from Maryland’s prestigious academic institutions.

“TEDCO is committed to remaining accessible to the ecosystem. As such, if founders are interested in learning more about our process, where their company may fit, or if they have questions about our process, we offer a monthly Investment Open Forum. This is a great opportunity to get questions

Longeviti Neuro Solutions, a neurotechnology company with a focus on innovative solutions for complex brain surgeries, proudly announces the issuance of a groundbreaking patent for its novel prosthetic translucent, cranial implant. The ClearFit® implant integrates brain-computer interface (BCI)

“We understand that a standardized approach to overseeing public influence of sports betting is needed, which is why I founded SharpRank,” said Christopher Adams, founder and chief executive officer at SharpRank. “Now, thanks to TEDCO’s investment, we can continue to grow and improve processes.”

TEDCO, Maryland’s economic engine for technology companies, has announced a substantial investment of $500,000 in Solaxa Inc., a pioneering biopharmaceutical company based in Bethesda, Maryland. This investment includes $200,000 from the State Small Business Credit Initiative (SSBCI) funding

“At Solaxa, we are developing neurorestorative treatments for children and adults suffering from rare neurodegenerative diseases and acute nerve injuries,” said Christian Walker, CEO and founder of Solaxa. “Thanks to TEDCO’s investment, we can accelerate our work to serve patients with